Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 10;27(8):2949–2958. doi: 10.1245/s10434-020-08304-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 2 — a Overall survival of all patients from cohorts A and B. The median overall survival in cohort A was 17 months (95% CI 13.9–20.1), compared with 18 months (95% CI 14.5–21.5) in cohort B (p = 0.987). b Overall survival of patients in cohorts A and B with PALN involvement who underwent bypass versus resection. Median survival was 7 months (95% CI 5.5–8.5) versus 11 months (95% CI 8.8–13.2; p = 0.049). c Overall survival of patients from cohorts A and B. All patients received postoperative chemotherapy. The median overall survival in cohort A was 24 months (95% CI 9.7–38.3), compared with 22 months (95% CI 15.3–28.7) in cohort B (p = 0.836). d Overall survival of patients in cohorts A and B with PALN involvement who underwent bypass versus resection. All patients received postoperative chemotherapy. Median survival was 11 months (95% CI 8.4–13.6) versus 13 months (95% CI 8.4–17.7; p = 0.033). CI confidence interval, PALN para-aortic lymph node